Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis

Detalles Bibliográficos
Autores principales: Küçükyurt, Selin, Kelezoğlu, Alihan, Elverdi, Tuğrul, Özmen, Deniz, Ar, Muhlis Cem, Eşkazan, Ahmet Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244240/
https://www.ncbi.nlm.nih.gov/pubmed/34210618
http://dx.doi.org/10.1016/j.htct.2021.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244240/
https://www.ncbi.nlm.nih.gov/pubmed/34210618
http://dx.doi.org/10.1016/j.htct.2021.04.007

Ejemplares similares